23 July 2019
From information on a condition or disease to emotional support, online influencers are taking a growing place in patients' lives. Alcimed, a consulting firm in innovation and new businesses, has explored the impact these influencers have on patients in terms of helping them understand their disease and potentially changing their attitude towards it.
18 July 2019
Article 51, a new item in the 2018 Social Security Financing Act, embodies the French government's objective to promote structural innovation in the healthcare sector. The exceptions from the usual organizational and financial rules proposed by this article open up new and promising horizons. However, the extent of these exceptions is still difficult to assess. Alcimed, a consulting company specializing in innovation and the development of new markets, discusses this article which, while arousing public interest, is still surrounded by some mystery.
16 July 2019
Chronic diseases are the leading causes of death around the world with 41 million people dying every year. However, their health impact can be significantly reduced by detecting early risk behaviors in the patient. Thanks to the daily collection of data, e-health can be a powerful tool to anticipate these behaviors and provide solutions for the prevention and management of chronic diseases. Alcimed, a consulting company specialized in innovation and new businesses, has looked into this issue.
12 July 2019
While the popularity of Bitcoin has gradually run out of steam, following the fall in its value, the general enthusiasm has now shifted to the technology that supported it: blockchain. The expectations fostered by this new way of transmitting information are such that blockchain is becoming an essential innovation theme in all sectors. Alcimed, a consulting company specializing in innovation and new businesses, examined the opportunities that this new technology offers to the healthcare sector, both in terms of promising perspectives and a changing legal framework.
9 July 2019
A solution to the lack of effectiveness of treatments for neurodegenerative diseases: targeting inflammation!
Due to the lack of certainty about their mechanism of action, research surrounding neurodegenerative diseases seems to be at an impasse. However, today, other therapeutic approaches are being considered, starting with neuroinflammation. Alcimed, an innovation and new business consulting firm, follows the advances of this research, which is opening up new treatment opportunities.
4 July 2019
The development of digital technologies offers the opportunity for pharmaceutical companies to think about doing things differently and better in many of their activities. ALCIMED, a consulting company in innovation and new businesses, analyses the opportunity offered by digital technology to acquire real-life patient data more easily and quickly.
2 July 2019
Alcimed, an innovation and new business consulting company, offers insights into the prospects related to the intestinal microbiota and the therapeutic issues arising from it.
27 June 2019
Air travel seems to be an increasingly feasible and promising solution to the major challenges of reducing congestion in overcrowded urban areas. The transition of urban transport to this third dimension raises many questions, particularly about regulatory aspects, societal acceptance, infrastructure deployment or the technological maturity of vehicles. But could we expect air taxis to become more widespread in the medium term? Alcimed, a consulting firm specializing in innovation and new businesses, takes a look at the barriers facing this market and its potential evolutions!
18 June 2019
According to a study conducted by Alcimed, most patients with vulvodynia would consult about 10 different healthcare professionals over several years before receiving the correct diagnosis associated to these symptoms.
14 June 2019
In today’s digital revolution – Industry 4.0, Big Data, Human Machine Interface (HMI), and intelligent connectivity – working environments are changing completely. While certain industries have already profoundly changed their processes, certain sectors such as Research are still in its infancy. Great technological upheavals are emerging and could strongly impact the field of Research. Alcimed, a consulting firm specializing in innovation, offers an overview of technologies that could transform the daily lives of researchers.
7 June 2019
Alcimed, an innovation and new business consulting firm, highlights the race for oligonucleotide therapeutics to catch peptides and discusses the current limitations for its widespread therapeutic use.
20 May 2019
Alcimed, an innovation & new business consulting firm, discusses current obstacles in the regulation of organ allocation in the United States with a brief look into potential innovative solutions, such as blockchain, in tackling some of these challenges.
8 April 2019
The energetic properties of the hydrogen molecule are mainly known in the automotive industry for their use in fuel cells. But a much less widespread and equally promising application is the use of hydrogen in industrial processes, particularly in the steel industry, as a substitute for natural gas or other carbon fuels. Alcimed, a consulting company specializing in innovation and the development of new markets, is studying the potential of hydrogen in the steel industry and reviewing the current industrial approaches in this field.
15 March 2019
With increasingly stringent CO2 emission reduction targets imposed by the European Union, manufacturers must keep pace. The first possible solution is the electrification of the automotive fleet. The second is the reduction of the weight of combustion vehicles to lower their emissions. Substituting metal parts with plastic or composite parts could lead to substantial weight savings. In terms of their properties, these materials reach the same level of performance as metals, but then why are our vehicles still mainly made of metal? ALCIMED, a consulting company specializing in innovation and the development of new markets, provides an overview of the use of plastic materials in the automotive industry and the obstacles to their widespread use.
18 February 2019
13 December 2018, In December 2006, the European Parliament adopted the Regulation on medicinal products for paediatric use aiming to stimulate pharmaceutical companies to develop medicinal forms intended for children. The European Medicines Agency (EMA) has been noting a significant increase in the number of new paediatric drugs; nevertheless, there is still a genuine need in this area. In fact, today, more than 50% of paediatric prescriptions are for off-label uses. Alcimed, an innovation and new business consulting firm, examined the factors that still limit the development of paediatric drugs, 10 years after the law was introduced.
18 February 2019
Although research is constantly moving forward, many neurodegenerative diseases remain poorly understood and grey areas still persist. Consequently, with the low number of effective drug treatments, new disease management methods are being developed. One of these methods is the serious games, alias “serious video games”, which are games developed to have a therapeutic effect. Just imagine if, after a doctor’s appointment, you found video game sessions on your prescription. Alcimed, a consulting company specializing in innovation and new businesses, set out to further explore this trend, which could radically impact current patient care.
26 February 2019
In response to the needs of streamlined processes and increased productivity, the use of Total Lab Automation (TLA) systems is massively increasing in medical biology laboratories. Alcimed, a consulting company specializing in innovation and new businesses, set out to highlight the potential of these workflow automation systems and question the related prospects for actors in vitro diagnostics.
14 December 2018
Alcimed, a consulting company specializing in innovation and new businesses, provides an update on the global sake market and outlines new trends in today's importing countries.
7 December 2018
Alcimed, a consulting company specializing in innovation and new businesses, talks about the development of "digital therapeutics" and its impact on the development of traditional therapies.
9 November 2018
The use of optical fibre for more than 20 years in the telecommunications industry has made a significant contribution to reducing the cost and improving the quality of components. This evolution has led to the development of a new type of application: fibre optic sensors, a particularly interesting technology in extreme conditions where the conventional electrical sensors are missing. Alcimed, a consulting company specializing in innovation and new businesses, reviews the functioning and benefits of these sensors.
5 November 2018
French consumers change their mobile phones every other year. These devices have significant impacts on the environment. Rather than keeping our old smartphones in our drawers, solutions exist to give old smartphones a second life to avoid keeping them in a drawer. Alcimed reviews how the smartphone valorization chain is gradually being implemented.
29 October 2018
Considered as an effective treatment against acne or premature skin ageing, blue light is subject to debate and is now the new priority of the cosmetics industry. From benefits to negative effects on our skin, Alcimed, an innovation consulting company, reviews the usage of blue light in cosmetic skin care products
26 October 2018
The elderly represent a high-potential target for the cosmetics industry. The share of the population aged 60 or over will increase by a factor of 2.5 by 2050 to reach 33% of the world's population. Moreover, the buying power of the elderly remains high, and they are more inclined to consume as they are driven by the desire to enjoy a new life after the age of 60. After targeting the elderly with anti-ageing products for a long time, cosmetics manufacturers wish to seduce them with the concept of "happy ageing" or "ageing well". What are the scientific claims behind happy ageing? Which brands are positioned on this concept and what products do they offer? Alcimed, an innovation consulting company, studies this new strategy of the cosmetics industry.
22 October 2018
It’s a fact: the French and global industrial sector is heavily depending on many raw materials to ensure its digital transformation and energy transition. How do we anticipate the future supply chain for rare metals, monopolistic raw materials, and metals with very low reserves? ALCIMED, an innovation and new business consulting firm, has reviewed the criteria impacting the criticality assessment of a raw material.
19 October 2018
Representing 9 out of the top 10 income-generating products on the market, biological drugs are now undoubtedly the main growth driver for the pharmaceutical industry. Big Pharma are looking not only to expand their portfolio with new macromolecules, but also to differentiate by offering delivery routes less invasive than injection for their blockbuster products. Oral delivery, long considered to be the Holy Grail, has been investigated for that objective for several years. How do market players position themselves in this race? Alcimed, an innovation and new business consulting firm, explores past and present challenges of these developments.
15 October 2018
ALCIMED, an innovation and new business consulting firm, studied food industry positioning in order to address plastic packaging challenges.
10 October 2018
With impressive results, particularly where conventional treatments have failed, CAR-T cells represent a real revolution in onco-hematology care. Two treatments are already available in the United States and are about to arrive in Europe. Alcimed, a consulting company specialized in innovation and the new businesses, has investigated this expensive therapy whose next challenge is undeniably its financing.
24 September 2018
Alzheimer is the most common neurodegenerative disease and is a source of great concern within our society. Currently, patients suffering from the condition are routinely treated with four drugs (and their generics). However, since August 1st 2018, after being deemed ineffective by the High Authority of Health (HAS), these drugs are no longer reimbursed in France. This decision, unique on a European scale, raises the question about care management of the 900,000 patients concerned1. The non-medicinal care available now, provides better support for patients, but the situation highlights the increased need to accelerate research to develop new curative molecules.
17 September 2018
ALCIMED, a consulting company specialised in innovation and the development of new businesses, is looking at the revival of innovation in the soft drinks sector.
10 September 2018
With more than 200 million patients suffering from Chronic Obstructive Pulmonary Disease (COPD), 235 million asthmatics, and 8.7 million patients affected by tuberculosis, respiratory diseases are gaining ground worldwide. Given these numbers and the impact on patients' quality of life, manufacturers are looking for innovations that could improve patient care. Alcimed, a consulting company specialized in innovation and new businesses, looked into the 5 key trends that will define the future of respiratory disease management.
20 August 2018
Alcimed, a consulting company specialized in innovation and new business development, reviews a new mega-trend in the pet food industry driven by owners’ expectations.
11 August 2018
Observations and evolution prospects for the PAERPA program within the frame of PTAs implementation.
Since 2016, the French Ministry of Social Affairs and Health has been rolling out their PAERPA program in one pilot territory per region, aiming at improving care for the ageing population and preventing the loss of its autonomy. Alcimed has supported several territories in the implementation of this program, both on the formalization of management procedures and on more operational aspects, capitalizing on the results of innovative actions carried out in the first pilot territories. The firm is now sharing its insight on the conditions for a successful roll-out and on the prospects of the PAERPA program in the context of the PTAs (Territorial Support Platforms) implementation.
27 July 2018
Alcimed, a consulting company specialized in innovation and new business development, studies employment challenges of the disabled at disability-friendly companies in France and presents the trends in public support for these companies.
26 July 2018
Alcimed, a consulting company specialized in innovation and new businesses, reports on the implementation of Territorial Hospital Groups (GHTs, French Acronym) led by the Ministry of Solidarity and Health, and in particular on the evolution of hospital purchases and their impact on suppliers.
9 July 2018
The Energy Transition requires raw materials present, in a quasi-monopolistic situation in some countries and whose reserves may be low, where recycling is difficult or is leading to strong societal and environmental impact. ALCIMED, a consulting company in Innovation and New Businesses, examines the status of certain raw materials related to the Energy Transition, their applications and their major issues.
28 June 2018
Alcimed, a consulting company specialized in innovation and new business development, provides an update on the risks associated with arboviruses worldwide and the strategies to fight these viruses.
24 June 2018
Alcimed, a consulting company specialized in innovation and new businesses, provides an update on the on the definition and challenges of preventive biology. As an integral part of "anti-aging" medicine it brings together applications at the frontiers of medicine and early diagnosis, sometimes incorporating controversial practices.
7 May 2018
Hydrogen, applied for the first time in the field of aerospace, particularly in the Apollo Program, is now invading our daily lives. The many initiatives around this promising energy vector and the creation of the International Hydrogen Council in 2017 (around the French groups Air Liquide, Alstom, Engie and Total) are clear signs that the hydrogen revolution is in motion. Its high energy efficiency and storage capacities position hydrogen as a substitute for fossil fuels and as an integrator of renewable energies.
23 April 2018
In response to societal demands for the availability of vitrification of oocytes and access to Assisted Reproductive Technologies (ART) for all women, the French Government has initiated national discussions that could potentially lead to evolutions in the context of medically assisted reproduction in France. Beyond the related ethical issues, a different type of challenge is emerging for ART and IVF (In vitro fertilization) centers: how to organize themselves to meet the increasing demand? Alcimed, a consulting company specialized in innovation and new business perspectives looked into the key future challenges lying ahead of these centers.
12 March 2018
Lightweight and flexible photovoltaic solutions are continuously being developed. Numerous projects are emerging, mainly due to increasing yields and falling prices. These technologies are opening the door to new applications which were otherwise inaccessible with heavy and rigid panels. ALCIMED, a consulting firm specialized in innovation and new businesses, reviewed this technological (r)evolution that is opening doors to a world of new photovoltaic applications!
1 March 2018
In a dynamic environment surrounding telemedicine in France, Alcimed, a consulting company specialized in innovation and new businesses, takes a look at this ecosystem and its projected future.
28 February 2018
While the global cosmetics market is growing steadily with annual growth rates of around 3.5%, natural and organic cosmetics seem to be doing even better with a projected annual rate reaching 10%. Plants have become an essential beauty ally, inviting themselves into the formulations of our cosmetic products. But beyond plant products that we traditionally find in our cosmetic departments such as aloe vera, shea butter, or argan oil, relying on the latest advances in research in herbal medicine, today's products appreciate the unknown plants with amazing properties. Alcimed, a consulting company specialized in innovation and new businesses, offers insights into these plants and the benefits they bring.
9 January 2018
Alcimed, a consulting company specialized in innovation and the developement of new markets, is looking into the growing use of drones for professional applications and the obstacles ans levers for their development.
13 December 2017
Four tailor-made cosmetics manufacturing strategies: from artisanal point-of-sale manufacturing to automated small batch production
Following the enthusiasm for tailor-made cosmetics and care, Alcimed, a consulting firm specialized in innovation and new market development, is taking a closer look at the strategies and technologies implemented by four French and Canadian cosmetic brands releasing their products in small series in order to meet the needs of a diverse community of consumers.
11 November 2017
E-Health – Technology benefiting the patient-physician relationship: what are the challenges and barriers?
Alcimed, a consulting company specialized in innovation and business development, is revisiting the promise of e-health and the challenges to be tackled to enable it to really take off in France.
6 November 2017
Faced with the profound changes in the agricultural world, the Government initiated the Etats Généraux de l’Alimentation (EGA, #egalim, https://www.egalimentation.gouv.fr) last June.
2 November 2017
Alcimed, a consulting company specializing in innovation and new market development, reports on the emergence of China, a player in the rapidly changing space industry, and its impact on historical players.
25 October 2017
Today, digital technologies are considered to be a chance for healthcare companies to reinvent the relationship with patients and healthcare professionals and capture business opportunities. Nevertheless, this redesign of exchanges between industrialists and environmental stakeholders has a strong impact on internal employees. Alcimed, a consulting company specialized in innovation and new market development, analyses the three challenges facing patients, healthcare professionals and collaborators for pharmaceutical companies.
19 October 2017
With more than one and a half million French people affected and no curative treatment available to date, psoriasis is a major public health issue. On the occasion of World Psoriasis Day on October 29th, Alcimed, a consulting company specializing in innovation and new business development, looks back at the latest developments in patient care and the main issues that have not yet been addressed.
18 October 2017
Following the authorization of the injection of biomethane into the gas network thanks to the decrees of 21 November 2011, the sector is booming. Alcimed, a consulting company specializing in innovation and the development of new markets, examines the many projects that are being developed and the evolution of the players in the sector. While some see this as an opportunity for development, others are forced to adapt to stay in the race.
12 October 2017
Alcimed, an innovation and new business consulting firm, works with the pharmaceutical and medical device industries, to leverage new technologies, partners, and trends for innovative products in mental health diagnosis.
9 October 2017
Solar panels have an average lifespan of 30 years. With the first panels installed in the 1980s and reaching now the end of their life, the solar industry is entering a pivotal period. How is the photovoltaic (PV) panel recycling industry structured around the world? What are the related economic and environmental challenges? Alcimed, a consulting company specializing in innovation and the development of new markets, discusses the afterlife of PV solar panels and the organization of the associated recycling services.
28 September 2017
Naturalness and health are becoming increasingly important in consumers’ eating habits. Alcimed, a consulting company specializing in innovation and the development of new markets, highlights the related challenges and prospects for the agri-food industry.
27 September 2017
Faced with situations of increasing complexity, healthcare professionals are in need of support to better coordinate their patients’ journeys. Alcimed, a consulting company specializing in innovation and the development of new markets, shares the lessons it learned from the work with ARS Bourgogne Franche-Comté on the implementation of territorial support platforms (Plateformes Territoriales d’Appui – PTA), which aim to provide an appropriate response to this issue.
26 September 2017
In 2015, Elon Musk, the founder and CEO of Tesla, announced the start of a revolution in energy management with the spectacular presentation of his home battery, the Powerwall. The revolution was to enable users to significantly reduce their energy bills and even achieve energy autonomy. So where are we today? Has this revolution had an impact on energy suppliers? Alcimed, a consulting company specializing in innovation and the development of new markets, takes a look at the state of this revolution, the current situation and the impact of these products on the business model of energy companies that are positioning themselves on this market.
8 September 2017
Alcimed, a consulting company specializing in innovation and the development of new markets, examines the challenges facing blood transfusion worldwide and outlines current and future alternatives that can improve blood management around the world.
30 August 2017
The thermal energy of our planet, coming from the heat of its nucleus and the natural radioactivity of its soils, is a formidable source of energy that, in contrast to renewable solar and wind energy, is continuously available. Alcimed, a consulting company specializing in innovation and the development of new markets, takes a look at the evolution of geothermal energy and the use of a potentially controversial technique: EGS (enhanced geothermal system).
28 July 2017
Alcimed, a consulting company specializing in innovation and the development of new markets, examined the context of sugar consumption and the development prospects it entails for manufacturers.
28 July 2017
More than just a messenger – The secret potential of RNA therapeutics in fighting cancer and respiratory diseases
Alcimed, an innovation and new business company, presents an outline of the future potential of messenger RNA (mRNA) therapeutics in addressing unmet needs.
20 June 2017
Alcimed, a consulting company specializing in innovation and the development of new markets, provides an update on the arrival of new services that have disrupted the business aviation sector in recent years. Between flight aggregation and integration of optimization services, digital technologies help to optimize operational costs.
20 June 2017
Alcimed, a consulting company specializing in innovation and the development of new markets, reviews the various pillars surrounding cats' wellbeing and the methods used to assess it.
19 June 2017
Alcimed, an innovation and new business consulting firm, highlights recent scientific developments in gene editing and discusses its future outlook.
12 June 2017
Alcimed, a consulting company specializing in innovation and the development of new markets, provides an update on the evolution of connectivity in aircrafts. Between the improvement of passengers’ experience and flight efficiency, connectivity is a key issue for airline companies.
4 June 2017
On the occasion of World Environment Day on June 5, Alcimed, a consulting company specializing in innovation and the development of new markets, discusses three key themes: water quality, smart agriculture and hydrogen mobility.
1 June 2017
Alcimed, a consulting company specializing in innovation and the development of new markets, takes a look at issues related to infertility and explores the current and future approaches that can provide better support for infertile couples.
24 May 2017
On the occasion of World Africa Day on May 25, Alcimed, a consulting firm specializing in innovation and the development of new markets, is revisiting the issue of access to healthcare in Africa. Access to treatments for infectious diseases (HIV, hepatitis B and C, malaria, tuberculosis, etc.) remains a challenge in Africa. Awareness of non-communicable diseases (heart attacks, stroke, cancer, COPD, etc.) is on the rise, and represents a novel challenge.
24 May 2017
Can the recent increase in the reimbursement of smoking cessation aids significantly reduce smoking in France?
19 May 2017
19 May 2017
17 May 2017
Alcimed, a consulting company specializing in innovation and the development of new markets, examines the arrival of new players and new services that have disrupted the space sector in the past few years. This trend, termed “New Space”, is breaking the traditional framework of satellite launch and operation.
17 May 2017
The increasing demand in emerging countries, the changing business landscape, the development of new vaccines and the appearance of new technologies for their administration are transforming the world of vaccines. Alcimed, consultants in innovation and development of new markets, reviews the change in the world vaccine market.
15 May 2017
Alcimed, a consulting company specializing in innovation and the development of new markets, examined Nutri-Score, the new voluntary nutritional labelling system which will be available in France from next April.
3 April 2017
Alcimed, a consulting company specializing in innovation and the development of new markets, has embarked on the exploration and analysis of a new underlying trend in industrial foods, driven by consumer choice: simplicity and naturalness.
20 April 2017
With a world production estimated at several million tons in 2015, the infant milk market is stagnating in Western countries. As a result, manufacturers have sought new opportunities in high-growth areas, and are also looking to reinvent themselves around new alternative offers. Alcimed, a consulting company specializing in innovation and the development of new markets, looks into the developments in the infant milk market and innovation prospects for industrialists.
13 April 2017
As cities pursue a zero emissions goal and users’ interest in cleaner and quieter engines increases, so does the demand for fully electric vehicles. However, one of the major obstacles to their expansion remains the range of at most 300 km, and the relatively long charging time (several hours).
11 April 2017
Specific Language and Learning Disorders (SLLD) in children and adolescents: towards structured responses to avoid pathway disruptions
In an average primary school class, it is estimated that 2 to 4 students require special support due to a Specific Language and Learning Disorder (SLLD). Despite the high prevalence, these disorders remain under-diagnosed and under-managed, which can lead to serious academic difficulties for children. Faced with these problems, the public authorities wish to implement stepwise responses, requiring the coordinated intervention of the various stakeholders. Alcimed is currently supporting the implementation of such structures in Normandy.
10 April 2017
After investing $3 billion in virtual and augmented reality projects in 2016, venture capital companies are now targeting “mixed reality”, considered as true augmented reality. For many analysts, 2017 could be the year of mixed reality. Blurring the boundaries between virtual and augmented reality by integrating virtual elements into the user’s real environment, mixed reality combines immersion and holography to make the real world and the virtual universe interact. Alcimed, a consulting company specializing in innovation and the development of new markets, examines the applications of this very promising technology.
7 April 2017
Theme-based campaigns in health care institutions: a participatory approach to support continuous improvement of professional practices and quality of care
The implementation of theme-based campaigns appears to be a new solution for improving professional practices and the quality of care through the engagement of institutions and teams. With its methodological expertise, Alcimed, a consulting company specializing in innovation and the development of new markets, is supporting healthcare and socio-medical players in these initiatives, particularly for the prevention of falls in Ile-de-France in 2015 and for access to healthcare for people with disabilities in the Alsace region in 2017.
3 April 2017
From decision support to the identification of new therapeutic targets, artificial intelligence (AI) is rapidly expanding in the field of health. Alcimed, a consulting and new market development consulting company, highlights the current potential of AI in healthcare and questions its future prospects.
21 March 2017
Water is a global issue in which agriculture plays a pivotal role. Agriculture already uses more than 70% of the world’s total water consumption, while the population growth, leading to a need for more agricultural production, is likely to increase this figure even further. Two main action topics are now emerging on the relationship between water and agriculture: better resource management and the preservation and control of water quality.
6 October 2017
Artificial intelligence (AI), nowadays present in many everyday applications, has just reached a milestone in research centers. “AI now outperforms people on unexpected tasks such as winning a poker tournament, sharpening an image in detective series or conducting a fluent conversation” says David Bariau, Partner at Alcimed.
5 July 2017
This year’s Agriculture Exhibition was once again an opportunity to reflect on many aspects, including respect for the environment, increasing production, optimizing farm management and ensuring the safety of farmers. It also made clear that the agriculture of the future must meet a dual objective of performance and sustainability.
17 March 2017
Alcimed, an innovation and new business consulting firm, remains committed to supporting the pharmaceutical industry in untangling the complex web of difficulties behind curing Alzheimer’s, a disease with one of the highest drug clinical trial failure rates.
28 February 2017
Alcimed, a consulting company specializing in innovation and the development of new markets, looks at the central role of raw materials for additive manufacturing technologies in the industrial sector.
16 May 2017
Alcimed, an innovation and new business consulting firm, is committed to supporting the pharmaceutical industry in exploiting the potential of new technologies such as stem cell therapy.